1. Liver stem cells—prospects for clinical use
David Tosh, Alastair Strain 
Journal of Hepatology 
Volume 42, Issue 1, Pages S75-S84 (April 2005)
DOI: /j.jhep
Copyright © 2004 European Association for the Study of the Liver Terms and Conditions

2. Fig. 1
Confocal immunofluorescence staining of human liver sections with the antibody GCTM5. Sections were co-stained with the biliary marker CK19 (Green), GCTM% (Red) and co-localisation showing in yellow in normal (A), Primary Biliary Cirrhosis (B) and Extra-hepatic Biliary Atresia (C) tissue. In each case the GCTM5 antibody recognises a sub-set of cells stained positive for CK19. In addition small number of discrete GCTM5 positive only cells are observed, even in normal tissue which may represent cells of the Canals of Hering.
Journal of Hepatology  , S75-S84DOI: ( /j.jhep )
Copyright © 2004 European Association for the Study of the Liver Terms and Conditions

3. Fig. 2
Conversion of pancreatic cells to hepatocytes. Control pancreatic cells express the exocrine digestive enzyme, amylase (A). Following dexamethasone treatment, some cells still express amylase (red) but a few flatten and start to express a liver phenotype based the gluconeogenic enzyme, glucose-6-phosphatase expression (green) (B).
Journal of Hepatology  , S75-S84DOI: ( /j.jhep )
Copyright © 2004 European Association for the Study of the Liver Terms and Conditions